why choose us

First received: August 4, 2022

Clinical Trial: Evaluate Bioequivalence of Micafungin (50mg/Vial)

Study Status: Completed

Recruit Status: Completed

Condition: A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of

Study Type: Interventional


Official Title: A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Micafungin (50 mg/Vial) After Intravenous Infusion of 50 mg Micafungin in Healthy Volunteers Under

Brief Summary: A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of micafungin (50 mg/vial) after intravenous infusion of 50 mg micafungin in healthy volunteers under fasting conditions

Read more